Approvals/TGA/CIPLA BUDESONIDE + FORMOTEROL 200/6 budesonide 160 microgram / formoterol fumarate dihydrate 4.5 microgram pressurised metered dose inhaler

Approved

STANDARD

CIPLA BUDESONIDE + FORMOTEROL 200/6 budesonide 160 microgram / formoterol fumarate dihydrate 4.5 microgram pressurised metered dose inhaler

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: Dec 9, 2025
Approval ID: 3d164a174bc1c76d
Company: Cipla Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: 3d164a174bc1c76d
Product Name: CIPLA BUDESONIDE + FORMOTEROL 200/6 budesonide 160 microgram / formoterol fumarate dihydrate 4.5 microgram pressurised metered dose inhaler
Artg Id: 437652
Artg Name: CIPLA BUDESONIDE + FORMOTEROL 200/6 budesonide 160 microgram / formoterol fumarate dihydrate 4.5 microgram pressurised metered dose inhaler
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2025-04-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/3380daabebb4f8097832917e86199cef.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/abcb26be4b3805222025b4b30a5cde28.pdf

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

3d164a174bc1c76d

Type

Standard

Back to TGA Approvals